Table 2.
Effects of pretreatment with lipoamide (LM) and lipoic acid (LA) on acrolein-induced decreases in mitochondrial functions
Ca | A | LM | LM+A | LA | LA + A | |
---|---|---|---|---|---|---|
GSH | 53.5±2.7b | 11.4±3.1† | 61.1±2.9 | 88.3±5.1** | 67.2±2.0 | 61.3±13.4** |
SOD | 79.6±2.1 | 54.8±0.6† | 77.6±1.4 | 77.1±4.7* | 75.7±2.6 | 72.8±5.7* |
T-AOC | 100 | 57.2±11.6† | 99.4±5.6 | 128.8±6.8** | 103.3±4.3 | 110.9±15.2* |
GST | 88.1±14.9 | 12.1±1.4† | 94.7±13.1 | 78.7±13.9** | 82.8±10.3 | 44.2±17.5 |
Experimental groups as in Table 1.
Values are means±SEM for assay-specific results of three or four independent experiments performed in triplicate. Intracellular GSH levels (mg/g protein), SOD activity (unit/mg protein), total antioxidant capacity (T-AOC;%), and GST activity (milli-OD/min) are presented.
p<0.01 vs control.
p<0.05 and p<0.01 vs acrolein.